Assay Development, Therapies, Trials and Workshop

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Assay Development

Therapies

Trials

Workshop

Article FDA Thank You The next chapter in the ctDNA story: Still promising, not ready for prime time

Agency IQ

JULY 21, 2023

The next chapter in the ctDNA story: Still promising, not ready for prime time A recent workshop summed up the state of play for circulating tumor DNA. The assessment of this benefit typically relies upon the use of specific endpoints to measure this clinical benefit, generally within the context of a clinical trial. [

FDA

FDA Clinical Trials DNA Treatment

Article EMA Thank You EMA finalizes clinical anticancer therapeutic guidance update

Agency IQ

FEBRUARY 2, 2024

EMA finalizes clinical anticancer therapeutic guidance update In a newly finalized revision, the EMA’s guideline covering all aspects of clinical development of anticancer therapeutics has expanded its already broad scope. This enables patient selection, stratification and other adjustment in clinical trial design planning.

Clinical Trials

Clinical Trials Trials Treatment Production

Drug Discovery Digest

Article FDA Thank You The next chapter in the ctDNA story: Still promising, not ready for prime time

Article EMA Thank You EMA finalizes clinical anticancer therapeutic guidance update

Stay Connected